Paper17496331
Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer.
Chen R and 9 others. Mol Cell Proteomics, 2007. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Papers, record 17496331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17496331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Pancreatic Neoplasms | Major topic |
| Pancreatitis, Chronic | Major topic |
| Proteome | Major topic |
| Humans | |
| Tandem Mass Spectrometry |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA107209 | NCI NIH HHS | United States | R01CA107209 | PubMed and NIH | NIH RePORTER |
| T32 CA080416 | NCI NIH HHS | United States | T32CA080416 | PubMed and NIH | NIH RePORTER |
| 1R01CA107209 | NCI NIH HHS | United States | R01CA107209 | PubMed and NIH | NIH RePORTER |
| N01-HV-28179 | NHLBI NIH HHS | United States | N01HV028179 | PubMed and NIH | NIH RePORTER |
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42015098 | Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42015098 | PubMed |
| 39949781 | Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/39949781 | PubMed |
| 39436604 | Deciphering Cancer Complexity: Integrative Proteogenomics and Proteomics Approaches for Biomarker Discovery. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39436604 | PubMed |
| 36923555 | Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome. | Cancer Res Commun | 2022 | https://conductscience.org/library/papers/36923555 | PubMed |
| 36745340 | New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy. | Clin Transl Oncol | 2023 | https://conductscience.org/library/papers/36745340 | PubMed |
| 35901239 | Protease-activated receptors in health and disease. | Physiol Rev | 2023 | https://conductscience.org/library/papers/35901239 | PubMed |
| 35884437 | Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884437 | PubMed |
| 33328982 | Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33328982 | PubMed |
| 33309859 | IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33309859 | PubMed |
| 32415356 | Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1. | J Mol Med (Berl) | 2020 | https://conductscience.org/library/papers/32415356 | PubMed |
| 32244327 | Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32244327 | PubMed |
| 31734355 | Proteome alterations in pancreatic ductal adenocarcinoma. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31734355 | PubMed |
| 31032145 | Proteomics Profiling of Pancreatic Cancer and Pancreatitis for Biomarkers Discovery. | J Cell Sci Ther | 2018 | https://conductscience.org/library/papers/31032145 | PubMed |
| 30771135 | Proteomic and genomic profiling of pancreatic cancer. | Cell Biol Toxicol | 2019 | https://conductscience.org/library/papers/30771135 | PubMed |
| 30404163 | A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. | Proteomes | 2018 | https://conductscience.org/library/papers/30404163 | PubMed |
| 30149613 | Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30149613 | PubMed |
| 29190982 | Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel. | Oncotarget | 2017 | https://conductscience.org/library/papers/29190982 | PubMed |
| 28627758 | Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. | Proteomics Clin Appl | 2017 | https://conductscience.org/library/papers/28627758 | PubMed |
| 28609370 | Proteins Differentially Expressed in the Pancreas of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice Fed Ethanol For 3 Months. | Pancreas | 2017 | https://conductscience.org/library/papers/28609370 | PubMed |
| 28603672 | Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stress. | PeerJ | 2017 | https://conductscience.org/library/papers/28603672 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA2 | 302 | PubTator's text mining | https://conductscience.org/library/genes/302 | NCBI Gene |
| CTSD | 1509 | PubTator's text mining | https://conductscience.org/library/genes/1509 | NCBI Gene |
| IGFBP2 | 3485 | PubTator's text mining | https://conductscience.org/library/genes/3485 | NCBI Gene |
| ITGB1 | 3688 | PubTator's text mining | https://conductscience.org/library/genes/3688 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17496331
GET https://conductscience.org/api/papers/v1/17496331/cited_by?page=2